Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Oligotropha carboxidovorans Sec-independent protein translocase protein TatA (tatA), partial CSB-YP478326OED
CSB-EP478326OED
CSB-BP478326OED
CSB-MP478326OED
CSB-EP478326OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans UPF0260 protein OCAR_6616/OCA5_c14500 (OCAR_6616, OCA5_c14500) CSB-YP478327OED
CSB-EP478327OED
CSB-BP478327OED
CSB-MP478327OED
CSB-EP478327OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans SsrA-binding protein (smpB) CSB-YP478328OED
CSB-EP478328OED
CSB-BP478328OED
CSB-MP478328OED
CSB-EP478328OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans Putative arginyl-tRNA--protein transferase (ate) CSB-YP478329OED
CSB-EP478329OED
CSB-BP478329OED
CSB-MP478329OED
CSB-EP478329OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans Probable cytosol aminopeptidase (pepA) CSB-YP478330OED
CSB-EP478330OED
CSB-BP478330OED
CSB-MP478330OED
CSB-EP478330OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans 50S ribosomal protein L13 (rplM) CSB-YP478331OED
CSB-EP478331OED
CSB-BP478331OED
CSB-MP478331OED
CSB-EP478331OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans 30S ribosomal protein S18 (rpsR) CSB-YP478332OED
CSB-EP478332OED
CSB-BP478332OED
CSB-MP478332OED
CSB-EP478332OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans Glutamate--tRNA ligase (gltX) CSB-YP478333OED
CSB-EP478333OED
CSB-BP478333OED
CSB-MP478333OED
CSB-EP478333OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP478334OED
CSB-EP478334OED
CSB-BP478334OED
CSB-MP478334OED
CSB-EP478334OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans Peptidyl-tRNA hydrolase (pth) CSB-YP478335OED
CSB-EP478335OED
CSB-BP478335OED
CSB-MP478335OED
CSB-EP478335OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP478336OED
CSB-EP478336OED
CSB-BP478336OED
CSB-MP478336OED
CSB-EP478336OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oligotropha carboxidovorans 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB) CSB-YP478337OED
CSB-EP478337OED
CSB-BP478337OED
CSB-MP478337OED
CSB-EP478337OED-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 50S ribosomal protein L32 (rpmF) CSB-YP478338HUY
CSB-EP478338HUY
CSB-BP478338HUY
CSB-MP478338HUY
CSB-EP478338HUY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB) CSB-YP478339HUY
CSB-EP478339HUY
CSB-BP478339HUY
CSB-MP478339HUY
CSB-EP478339HUY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Exodeoxyribonuclease 7 large subunit (xseA) CSB-YP478340HUY
CSB-EP478340HUY
CSB-BP478340HUY
CSB-MP478340HUY
CSB-EP478340HUY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Glutamate-1-semialdehyde 2,1-aminomutase (hemL) CSB-YP478341HUY
CSB-EP478341HUY
CSB-BP478341HUY
CSB-MP478341HUY
CSB-EP478341HUY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP478342HUY
CSB-EP478342HUY
CSB-BP478342HUY
CSB-MP478342HUY
CSB-EP478342HUY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 3-dehydroquinate dehydratase (aroQ) CSB-YP478343HUY
CSB-EP478343HUY
CSB-BP478343HUY
CSB-MP478343HUY
CSB-EP478343HUY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Dihydrodipicolinate reductase (dapB) CSB-YP478344HUY
CSB-EP478344HUY
CSB-BP478344HUY
CSB-MP478344HUY
CSB-EP478344HUY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 50S ribosomal protein L31 (rpmE) CSB-YP478345HUY
CSB-EP478345HUY
CSB-BP478345HUY
CSB-MP478345HUY
CSB-EP478345HUY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>